Dr. Daniel Adam Graubert, M.D. Anesthesiology - Addiction Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 Route 108, Somersworth, NH 03878 Phone: 603-692-3166 Fax: 603-692-3168 |
News Archive
Almost half of women in the US who suffer from Type 1 or 2 diabetes report that it has a negative impact on their sex lives, according to a new study released today by MicroMass Communications, Inc., a leader in behavioral marketing in the healthcare industry. The research, which highlighted the need for improved education and support to help women build confidence in their ability to overcome the challenges of the disease, was conducted with a representative sample of more than 800 women with diabetes.
Strategies for decreasing a child's risk for obesity often focus on improving eating habits and maintaining a high level of physical activity.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Omeros Corporation today announced additional positive data in the company's Phase 2 clinical trial of OMS721 for the treatment of thrombotic microangiopathies (TMAs). TMAs are a family of rare, debilitating and life-threatening disorders characterized by excessive thrombi (clots) – aggregations of platelets – in the microcirculation of the body's organs, most commonly the kidney and brain.
Stem cell research at the University of California, Riverside is about to gather speed thanks to the establishment of a new Stem Cell Core Facility (SCCF) - a shared facility providing infrastructure, equipment, and trained personnel for doing stem cell research that ordinarily would not be available in most laboratories.
› Verified 2 days ago